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background: It has been postulated that Chagas Disease Cardiomyopathy (CD CMP) is associated with an elevated risk of stroke, but current 
data is conflicting and prospective controlled studies are lacking. We aimed to do a systematic review and meta-analysis of the association between 
stroke and CD CMP.
Methods: PubMed, EMBASE, Cochrane Central and unpublished data were searched with the following terms: “Chagas disease” AND (“stroke” OR 
“cerebrovascular accident”). We included studies that reported prevalence or incidence of stroke in a group of CD CMP compared to a non-CD CMP 
control group. Random-effect model odds ratio were computed. Heterogeneity was assessed with I2 statistics.
results: A total of five studies and 2,922 patients were included. Only one study (Lima-Costa 2010) compared a cohort of asymptomatic CD CMP 
to non-CD CMP patients. All other studies compared symptomatic CD-CMP to other causes of cardiomyopathy, which the majority was ischemic. 
Ejection fraction was similar between groups in all studies (51 ± 15 vs 48 ± 12 for CD CMP and non CD CMP respectively, p > 0.05). Prevalence of 
stroke (OR 1.76; CI 1.28-2.42; p=0.0005; figure 1) were statistically more prevalent in patients with CD CMP.
conclusion: This meta-analysis found that CD CMP is statistically associated with an increased prevalence of stroke due to unclear mechanisms. 
These findings suggest that a more aggressive anti-coagulation strategy should be studied in such patients.
 
